Mr Mfazo Hove Featured in Newsweek: GLP-1 Medications and Vision Loss Posted Medically Reviewed by: Mr Mfazo Hove, Consultant Ophthalmic Surgeon Author: Chris Dunnington Published: July 16, 2026 Last Updated: July 16, 2026 Mr Mfazo Hove, Consultant Ophthalmic Surgeon and Medical Director of Blue Fin Vision, has been invited by Newsweek to comment on new international research linking GLP-1 medications to a rare optic nerve condition that can cause sudden vision loss
The crude product is then purified and lyophilized into 30 mg vials, ready to enter analytical release
Overall, life after Zepbound feels more hopeful, balanced, and fulfilling. I got my groove back now. Stephanie T., 43 When it came to losing weight, Stephanie had tried a little bit of everything, from appetite suppressants and fat burners to juice cleansers and meal delivery services
1.4% for seven months, and another 1.4% reported using them for nine months